Viewing Study NCT03012620

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-03-03 @ 12:44 AM
Study NCT ID: NCT03012620
Status: COMPLETED
Last Update Posted: 2024-02-28
First Post: 2017-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Sponsor: UNICANCER
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
None Ovarian Neoplasm View
None Central Nervous System Neoplasm View
None Thyroid Neoplasm View
None Carcinoma, Neuroendocrine View
None Neoplasms, Germ Cell and Embryonal View
None NK/T-cell Lymphoma View
Keywords: